DGCI approves market authorisation of Serum Institute's Covovax as booster dose

Jan 17, 2023

This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin.

Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster

Sep 11, 2022

New Delhi [India], September 11 : Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous...

DCGI approves India's first qHPV vaccine to treat cervical cancer

Jul 12, 2022

New Delhi [India], July 12 : India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India (DCGI) approval...

DCGI recommends Covovax as heterologous booster dose

Jan 12, 2023

The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as...

SEC recommends India's first indigenously developed vaccine against cervical cancer for 9 to 26-year age group

Jun 15, 2022

New Delhi [India], June 15 : The subject expert committee meeting that was scheduled today to discuss Serum Institute of India's (SII) indigenously developed...

DGCI arrests 215 people in fake invoice cases in 2 months

Jan 10, 2021

New Delhi [India], January 10 : As many as 215 people have been arrested in the last two months by the Directorate General of...